Recent Research from the ODPRN

Journal Articles

Geographic variation and sociodemographic correlates of prescription psychotropic drug use among children and youth in Ontario, Canada

This study quantifies the extent of geographic variability in prescription psychotropic dispensing to children and youth and identifies sociodemographic correlates of use.

January 11, 2023

Medication errors in community pharmacies: Evaluation of a standardized safety program

This study evaluates the uptake in reporting of medication-related events since the launch of the AIMS Program in 2018, describes reporting trends, and identifies initial learnings that can be used to help develop strategies to prevent future medication errors in community pharmacies.

January 3, 2023

Changing patterns of opioid initiation for pain management in Ontario, Canada: A population-based cross-sectional study

This study sought to characterize how well opioid initiation practices aligned with opioid prescribing recommendations before and following the release of a national guideline.

December 8, 2022

Impact of policy changes and drug shortages on acamprosate and naltrexone use in Ontario, Canada

This study evaluated the impact of policy changes and drug shortages on the use of acamprosate and naltrexone, evidence-based pharmacotherapies for alcohol use disorder (AUD) in Ontario, Canada.

December 1, 2022

Public Reports

Contributions of stimulants and varying modes of drug use to opioid toxicity deaths across public health units in Ontario, Canada

This report examines the involvement of stimulants overall, and specifically non-pharmaceutical stimulants (i.e., cocaine and methamphetamines), as well as modes of drug use (e.g. inhalation/smoking vs. injection) in accidental opioid toxicity deaths occurring in Ontario between January 2018 and June 2021.

November 29, 2022

Ontario Opioid Indicator Tool: Harm Reduction Dashboard (New!)

The landscape of the overdose crisis in Ontario has shifted, with an increasing recognition that the majority of opioid-related harms have been associated with the unregulated opioid supply, which is predominantly made up of fentanyl. To better meet the needs of the current crisis, this online tool has been updated with new indicators focused on harm reduction.

November 2, 2022

“Everyone sees me as super successful, but I’ve been struggling for years”: What we heard at the Town Hall on access to treatment and services for ADHD into adulthood

The Inaugural Town Hall was held on July 27, 2022 and focused on navigating attention deficit hyperactivity disorder (ADHD) into adulthood. Read the report + listen to the audio clips from 7 of the individuals who shared live during the Town Hall as well as 4 individuals who shared their story following the Town Hall.

October 28, 2022

Lives lost to opioid toxicity among Ontarians who worked in the construction industry

This new report provides information on the disproportionate impact of opioid toxicity deaths among people working in the construction industry in Ontario + a support resource for individuals in the construction industry interested in learning more about tips for safer drug use and treatment options.

July 28, 2022

Additional Resources

Please note that this report is NOT COMPLETE and is still in progress. Click below if you would like to continue.